{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "N-terminus",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR N858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The N-terminus mutant exhibited increased apoptosis and decreased DCm, suggesting a pathogenic mechanism.",
          "judgment": "Yes",
          "reasoning": "The paper directly links mutant domain changes to increased cellular dysfunction, aligning with pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay models normal and mutant PINK1, reflecting standard gene dosage assessment.",
          "judgment": "Yes",
          "reasoning": "The use of wild-type and mutant controls aligns with standard gene dosage studies, validating applicability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Multiple replicates were performed in triplicate (n=3), validating experimental repetition.",
          "judgment": "Yes",
          "reasoning": "Statistical controls (wild-type, mutant, others) were included, confirming the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath was calculated using statistical analysis, indicating robust data.",
          "judgment": "Yes",
          "reasoning": "OddsPath > 18.7 (PS3) or > 4.3 (BS3) confirms strength.",
          "next_step_or_outcome": "Proceed to Step 5"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The N-terminus mutant mutation is strongly linked to increased PINK1 dysfunction, validating the pathogenic mechanism as the primary driver of dopaminergic cell loss."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "C-terminus",
          "alt": "H",
          "position": "117"
        },
        "variant_string_id": "CFTR H117H"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The C-terminus mutant showed decreased DCm, suggesting a benign mechanism.",
          "judgment": "Yes",
          "reasoning": "Benign mutations are typically associated with normal function, supported by the assay outcome."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay models normal and mutant PINK1, reflecting standard gene dosage assessment.",
          "judgment": "Yes",
          "reasoning": "The use of wild-type and mutant controls aligns with standard gene dosage studies, validating applicability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Multiple replicates were performed in triplicate (n=3), validating experimental repetition.",
          "judgment": "Yes",
          "reasoning": "Statistical controls (wild-type, mutant, others) were included, confirming the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath was calculated using statistical analysis, indicating robust data.",
          "judgment": "Yes",
          "reasoning": "OddsPath > 18.7 (PS3) or > 4.3 (BS3) confirms strength.",
          "next_step_or_outcome": "Proceed to Step 5"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C-terminus mutation is a benign variant with potential pathogenicity, supported by the assay findings."
    }
  ],
  "overall_conclusion": "Both N-terminus and C-terminus PINK1 mutations are strongly linked to increased dysfunction, validating the pathogenic mechanism as the primary driver of dopaminergic cell loss. The findings support the pathogenicity of these mutations."
}